Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-08

Clinical Trial Update: Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation

View source ↗

Summary

An ongoing clinical trial update from Peking University Third Hospital examining whether fibroblast growth factor 23 levels are associated with recurrence of at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University Third Hospital | Conditions: Atrial Fibrillation | Status: UNKNOWN